期刊文献+

血管新生性治疗中基因转移系统及其应用的研究进展 被引量:3

Progress of application of gene transfer system in therapy of angiogenesis
下载PDF
导出
摘要 近年来 ,缺血性心血管疾病的血管新生性治疗的研究进展迅猛 ,本文就血管新生性治疗中基因转移载体的选择及其应用途径两方面作一综述。 The search for the angiogenesis therapy in the field of ischemical cardiovascular diseases has made rapid progress in the past years.The aim of this review was to summarize the choices of gene transfer vectors and evaluate the ways of their applications in the angiogenesis therapy.
出处 《医学研究生学报》 CAS 2004年第1期68-70,共3页 Journal of Medical Postgraduates
关键词 血管新生 基因疗法 基因转移 研究进展 载体 缺血性心血管疾病 Angeogenesis Gene therapy Gene transfer
  • 相关文献

参考文献23

  • 1[1]Veit K, Boissel JP, Buerke M et al. Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells[J]. Cardiovasc Res,1999,43(5):808-822.
  • 2[2]Dzau VJ, Mann MJ,Morishitar R et al.Fusigenicviral liposome for gene therapy in cardiovascular disease[J]. Proc Natl Acad Sci USA,1996,93(6):1421-1425.
  • 3[3]Wang Y,Boros P,Liu J et al.DNA/dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo[J]. Mol Ther,2000,2(6):602-608.
  • 4[4]Lee RJ, Springer ML, Blanco-Bose WE et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression[J]. Circulation, 2000, 102(4):898-901.
  • 5[5]French BA, Mazur W, Geske RS et al. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors[J]. Circulation,1994, 90(1): 2414-2424.
  • 6[6]Kalka C, Tehrani H, Laudenberg B et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease[J]. Ann Thorac Surg,2000,70:829-834.
  • 7[7]Morsy MA. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene[J]. Proc Natl Acad Sci USA,1998, 95:7866-7871.
  • 8[8]Kibbe MR, Murdock A, Wickham T et al. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors[J]. Arch Surg,2000,135(2):191-197.
  • 9[9]Wolgang M Franz,Thomas Rothmann,Norbert Frey et al. Analysis of tissues specific gene dilevery by recombinant adenoviruses containing cardiac-specific promoters[J].Cardiovas Res,1997, 35(3): 560-566.
  • 10[10]Papapetropoulos A, Garcia-Cardena G, Dengler TJ et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors[J]. Lab Invest, 1999,79(2):213-223.

二级参考文献4

  • 1[1]Losordo DW, Vale PR, Isner JM ,et al.Gene therapy for myocardial angiogenesis[J].Am Heart J, 1999,138:132-141.
  • 2[2]Yibin Wang,Shuang Huang. Adenovirus technology for gene manipulation and functional studies[J].Drug Discovery Today, 2000,5:10-16.
  • 3[3]Lemarchand P, Jones M, Yamada I,et al.In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors[J].Circ Res, 1993,72:1132-1138.
  • 4[4]Giordano FJ. Intracoronary transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart[J].Nature Med, 1996,2:534-539.

共引文献2

同被引文献38

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部